Skip to main content

Table 3 A comparison of the mean laboratory parameters in the case and control groups and their relationships [mean ± SD (min-max)]

From: Correlation between serum vitamin D level and neonatal indirect hyperbilirubinemia

Variables

Study group (n = 30)

Control group (n = 30)

P

Ca (mg/dL)

9.21 ± 0.73 (7.7–10.7)

9.30 ± 0.58 (8.2–10.4)

0.256

P (mg/dL)

5.98 ± 0.82 (4.6–7.6)

5.73 ± 0.69 (4.3–7.3)

0.173

ALP (U/L)

409 ± 102 (247–647)

373 ± 106 (232–680)

0.895

Mg (mg/dL)

1.95 ± 0.20 (1.7–2.4)

1.99 ± 0.16 (1.7–2.3)

0.075

Neonate’s 25-OH vit D (ng/mL)

10.76 ± 8.60 (0.8–30.8)

14.88 ± 11.38 (5.1–68)

0.119

  < 5 ng/mL [n (%)]

5 (17)

0 (0)

 

 5–10 ng/mL [n (%)]

16 (53)

10 (33)

 

 10–20 ng/mL [n (%)]

3 (10)

14 (47)

 

 20–30 ng/mL [n (%)]

5 (17)

5 (17)

 

 30–50 ng/mL [n (%)]

1 (3)

0 (0)

 

 50–70 ng/mL [n (%)]

0 (0)

1 (3)

 

Mother’s 25-OH vit D (ng/mL)

14.72 ± 9.6 (3.6–44.9)

17.71 ± 12.66 (5.0–72.8)

0.307

  < 5 ng/mL [n (%)]

2 (7)

0 (0)

 

 5–10 ng/mL [n (%)]

12 (40)

8 (27)

 

 10–20 ng/mL [n (%)]

7 (23)

12 (40)

 

 20–30 ng/mL [n (%)]

7 (23)

7 (23)

 

 30–50 ng/mL [n (%)]

2 (7)

2 (7)

 

 50–70 ng/mL [n (%)]

0 (0)

1 (3)

 
  1. Ca calcium, P phosphate, ALP alkaline phosphatase, Mg magnesium, 25-OH vit D 25-hydroxy vitamin D
  2. t-test and frequency and percentage tests are used in this table